These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18221172)

  • 1. Structural development, haematological immunological and pharmacological effects of quinolones.
    Chide OE; Orisakwe OE
    Recent Pat Antiinfect Drug Discov; 2007 Jun; 2(2):157-68. PubMed ID: 18221172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacin.
    Kocsis B; Domokos J; Szabo D
    Ann Clin Microbiol Antimicrob; 2016 May; 15(1):34. PubMed ID: 27215369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of the quinolones.
    Andersson MI; MacGowan AP
    J Antimicrob Chemother; 2003 May; 51 Suppl 1():1-11. PubMed ID: 12702698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoroquinolone adverse effects and drug interactions.
    Fish DN
    Pharmacotherapy; 2001 Oct; 21(10 Pt 2):253S-272S. PubMed ID: 11642691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of antimicrobial agents. 3. Syntheses and antibacterial activities of 7-(4-hydroxypiperazin-1-yl)quinolones.
    Uno T; Kondo H; Inoue Y; Kawahata Y; Sotomura M; Iuchi K; Tsukamoto G
    J Med Chem; 1990 Oct; 33(10):2929-32. PubMed ID: 2170653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments of quinolone-based derivatives and their activities against Escherichia coli.
    Gao F; Wang P; Yang H; Miao Q; Ma L; Lu G
    Eur J Med Chem; 2018 Sep; 157():1223-1248. PubMed ID: 30193220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety.
    Emami S; Foroumadi A; Faramarzi MA; Samadi N
    Arch Pharm (Weinheim); 2008 Jan; 341(1):42-8. PubMed ID: 18072241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial agents (oxazolidinones, quinolones, macrolides and new agents): patent highlights June to December 2000.
    Phillips OA; Matowe WC
    Curr Opin Investig Drugs; 2001 Jun; 2(6):745-51. PubMed ID: 11572651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Substituted piperazinyl quinolones as potential cytotoxic agents: structure-activity relationships study.
    Foroumadi A; Emami S; Rajabalian S; Badinloo M; Mohammadhosseini N; Shafiee A
    Biomed Pharmacother; 2009 Mar; 63(3):216-20. PubMed ID: 18328669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activity of 4''-O-acyl derivatives of 14- and 15-membered macrolides linked to omega-quinolone-carboxylic unit.
    Skugor MM; Stimac V; Palej I; Lugarić D; Paljetak HC; Filić D; Modrić M; Dilović I; Gembarovski D; Mutak S; Eraković Haber V; Holmes DJ; Ivezić-Schoenfeld Z; Alihodzić S
    Bioorg Med Chem; 2010 Sep; 18(17):6547-58. PubMed ID: 20621489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nemonoxacin (TG-873870) for treatment of community-acquired pneumonia.
    Lai CC; Lee KY; Lin SW; Chen YH; Kuo HY; Hung CC; Hsueh PR
    Expert Rev Anti Infect Ther; 2014 Apr; 12(4):401-17. PubMed ID: 24579813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on 6-aminoquinolones: synthesis and antibacterial evaluation of 6-amino-8-methylquinolones.
    Cecchetti V; Fravolini A; Lorenzini MC; Tabarrini O; Terni P; Xin T
    J Med Chem; 1996 Jan; 39(2):436-45. PubMed ID: 8558512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunobiological efficacy and immunotoxicity of novel synthetically prepared fluoroquinolone ethyl 6-fluoro-8-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylate.
    Jantová S; Paulovičová E; Paulovičová L; Janošková M; Pánik M; Milata V
    Immunobiology; 2018 Jan; 223(1):81-93. PubMed ID: 29030009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel oxazolidinone-quinolone hybrid antimicrobials.
    Gordeev MF; Hackbarth C; Barbachyn MR; Banitt LS; Gage JR; Luehr GW; Gomez M; Trias J; Morin SE; Zurenko GE; Parker CN; Evans JM; White RJ; Patel DV
    Bioorg Med Chem Lett; 2003 Dec; 13(23):4213-6. PubMed ID: 14623004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterocyclic urea derivatives and methods of use thereof (WO2010142978).
    Supuran CT; Scozzafava A
    Expert Opin Ther Pat; 2012 Feb; 22(2):193-7. PubMed ID: 22264034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and anti-mycobacterial activities of triazoloquinolones.
    Carta A; Palomba M; Briguglio I; Corona P; Piras S; Jabes D; Guglierame P; Molicotti P; Zanetti S
    Eur J Med Chem; 2011 Jan; 46(1):320-6. PubMed ID: 21145625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of (3S)-amino-(4R)-ethylpiperidinyl quinolones as potent antibacterial agents with a broad spectrum of activity and activity against resistant pathogens.
    Hu XE; Kim NK; Gray JL; Almstead JI; Seibel WL; Ledoussal B
    J Med Chem; 2003 Aug; 46(17):3655-61. PubMed ID: 12904069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antibacterial activity of FA103, a new quinolone derivative of C-7 position with 7-perhydrodiazepinone.
    Imamori K; Asaoka T; Matsumoto M; Maebashi K; Matsuda H; Tahara Y
    Jpn J Antibiot; 1995 Dec; 48(12):1891-8. PubMed ID: 8587163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Safety profile of antimicrobial agents].
    Hori S
    Yakugaku Zasshi; 2011; 131(10):1423-8. PubMed ID: 21963968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.